Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Sileon Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Sileon şirketinin toplam hissedar öz sermayesi SEK10.5M ve toplam borcu SEK56.2M olup, bu da borç-öz sermaye oranını 533.5% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla SEK168.4M ve SEK157.9M dir.

Anahtar bilgiler

533.5%

Borç/özkaynak oranı

SEK 56.18m

Borç

Faiz karşılama oranı	n/a
Nakit	SEK 7.50m
Eşitlik	SEK 10.53m
Toplam yükümlülükler	SEK 157.87m
Toplam varlıklar	SEK 168.40m

Son finansal sağlık güncellemeleri

Recent updates

Sileon (STO:SILEON) Is Carrying A Fair Bit Of Debt

May 04

Is Sileon (STO:SILEON) A Risky Investment?

Aug 28

Does Paynova (NGM:PAY) Have A Healthy Balance Sheet?

Feb 02

Paynova (NGM:PAY) Is Making Moderate Use Of Debt

May 27

Is Paynova (NGM:PAY) A Risky Investment?

Feb 11

This Insider Has Just Sold Shares In Paynova AB (NGM:PAY)

Dec 20

A Quick Analysis On Paynova's (NGM:PAY) CEO Compensation

Dec 03

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: SILEON 'nin kısa vadeli varlıkları ( SEK95.5M ) kısa vadeli yükümlülüklerini ( SEK116.6M ) kapsamıyor.

Uzun Vadeli Yükümlülükler: SILEON şirketinin kısa vadeli varlıkları ( SEK95.5M ) uzun vadeli yükümlülüklerini ( SEK41.2M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: SILEON 'nin net borç/öz sermaye oranı ( 462.2% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: SILEON şirketinin borç/öz sermaye oranı son 5 yılda 181.6% seviyesinden 533.5% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: SILEON son raporlanan serbest nakit akışına göre 2 ay boyunca yeterli nakit pistine sahiptir, ancak o zamandan beri ek sermaye artırmıştır.

Tahmini Nakit Akışı: SILEON serbest nakit akışı tahminlerine göre 8 ay boyunca yeterli nakit akışına sahip olması öngörülüyor, ancak o zamandan beri ek sermaye artırdı.

Sileon Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Sileon (STO:SILEON) Is Carrying A Fair Bit Of Debt

Is Sileon (STO:SILEON) A Risky Investment?

Does Paynova (NGM:PAY) Have A Healthy Balance Sheet?

Paynova (NGM:PAY) Is Making Moderate Use Of Debt

Is Paynova (NGM:PAY) A Risky Investment?

Recent updates

New minor risk - Profitability

Second quarter 2024 earnings released: kr0.10 loss per share (vs kr0.42 loss in 2Q 2023)

New major risk - Shareholder dilution

Sileon AB (publ) Unveils Innovative Feature as Part of its Comprehensive SaaS Offering

Forecast breakeven date pushed back to 2025

Sileon AB (publ) Announces Chairman Changes

Sileon AB (publ) has filed a Follow-on Equity Offering.

First quarter 2024 earnings released: kr0.21 loss per share (vs kr0.32 loss in 1Q 2023)

Full year 2023 earnings released: kr1.44 loss per share (vs kr1.25 loss in FY 2022)

Sileon AB (publ), Annual General Meeting, Apr 16, 2024

Sileon AB (publ), Annual General Meeting, Apr 16, 2024

New major risk - Share price stability

New major risk - Financial position

Third quarter 2023 earnings released: kr0.43 loss per share (vs kr0.14 loss in 3Q 2022)

Sileon AB (publ) to Report Fiscal Year 2023 Results on Feb 16, 2024

New minor risk - Shareholder dilution

High number of new and inexperienced directors

New minor risk - Shareholder dilution

Sileon AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 33.793604 million.

Sileon AB (publ) Expands Product Line and Opens A Trial Account for Self-Onboarding

Second quarter 2023 earnings released: kr0.42 loss per share (vs kr0.38 loss in 2Q 2022)

Sileon AB (publ) Launches its First Complementing Solution Module - Risk Assessment

High number of new and inexperienced directors

Independent Chairman of the Board recently bought kr268k worth of stock

Sileon (STO:SILEON) Is Carrying A Fair Bit Of Debt

Full year 2022 earnings: EPS and revenues miss analyst expectations

Independent Chairman of the Board recently bought kr512k worth of stock

Independent Chairman of the Board recently bought kr512k worth of stock

Full year 2022 earnings released: kr0.94 loss per share (vs kr3.05 loss in FY 2021)

Forecast to breakeven in 2024

Chairman of the Board recently bought kr296k worth of stock

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to kr4.70

Less than half of directors are independent

Is Sileon (STO:SILEON) A Risky Investment?

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Consensus revenue estimates increase by 14%

Price target decreased to kr4.70

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Does Paynova (NGM:PAY) Have A Healthy Balance Sheet?

Third quarter 2021 earnings: EPS in line with expectations, revenues disappoint

Independent Director recently bought kr75k worth of stock

Independent Director recently bought kr220k worth of stock

Second quarter 2021 earnings released: kr0.67 loss per share (vs kr1.29 loss in 2Q 2020)

Independent Director recently sold kr226k worth of stock

Chairman of the Board recently bought kr300k worth of stock

Paynova (NGM:PAY) Is Making Moderate Use Of Debt

First quarter 2021 earnings released: kr1.07 loss per share (vs kr1.03 loss in 1Q 2020)

Full year 2020 earnings released: kr4.62 loss per share (vs kr6.96 loss in FY 2019)

Independent Director recently sold kr296k worth of stock

Is Paynova (NGM:PAY) A Risky Investment?

Full year 2020 earnings released: kr4.62 loss per share (vs kr6.96 loss in FY 2019)

New 90-day low: kr13.70

Independent Director recently bought kr71k worth of stock

This Insider Has Just Sold Shares In Paynova AB (NGM:PAY)

Chairman of the Board & President recently sold kr2.4m worth of stock

A Quick Analysis On Paynova's (NGM:PAY) CEO Compensation

Third quarter 2020 earnings released: kr1.16 loss per share

Paynova AB announced that it has received SEK 15.500085 million in funding from Roosgruppen AB, Rieberg & Soen AS

Paynova AB announced that it expects to receive SEK 15.499995 million in funding

Earnings released

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin